Skip Navigation

Neuro-Oncology 2009 11(3):318-322; doi:10.1215/15228517-2008-103
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pulido, J. S.
Right arrow Articles by O'Neill, B. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pulido, J. S.
Right arrow Articles by O'Neill, B. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright 2009 by the Society for Neuro-Oncology

Racial differences in primary central nervous system lymphoma incidence and survival rates

Jose S. Pulido, Robert A. Vierkant, Janet E. Olson, Lauren Abrey, David Schiff and Brian Patrick O'Neill

Departments of Ophthalmology, Health Sciences Research, and Neurology, Mayo Clinic and Foundation and the Mayo Clinic Cancer Center, Rochester, MN (J.S.P., R.A.V., J.E.O., B.P.O.); Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY (L.A.); Departments of Neurology and Neurosurgery, University of Virginia Health System, Charlottesville, VA (D.S.); USA

Address correspondence to Jose S. Pulido, Mayo Clinic, Department of Ophthalmology, 200 First St., SW, Rochester, MN 55905, USA (pulido.jose{at}mayo.edu).


   Abstract

To determine racial and ethnic differences in incidence and survival in patients with primary central nervous system lymphoma (PCNSL), NCI Surveillance, Epidemiology, and End Results (SEER) program data from 1992 to 2002 were queried. Data were substratified by age (20–49 years vs. 50 or above) and race (White, Black, Asian/Pacific Islander [A/PI], American Indian/Alaskan Native [AI/AN]). Incidence of PCNSL and survival were calculated by SEER*Stat software. The incidence rates were 0.94 per 100,000 per year (95% confidence interval [CI] 0.90–0.98) for Whites, 1.10 (95% CI 0.98–1.22) for Blacks, 0.51 (95% CI 0.28–0.74) for AI/AN, and 0.64 (95% CI 0.56–0.72) for A/PI. In patients aged 20–49 years the rates were 0.72 (95% CI 0.68–0.76) for Whites, 1.43 (95% CI 1.27–1.59) for Blacks, 0.58 (95% CI 0.30–0.86) for AI/AN, and 0.21 (CI 0.15–0.27) for A/PI. In patients over 49 years, the rates were 1.30 (95% CI 1.22–1.38) for Whites, 0.56 (95% CI 0.40–0.72) for Blacks, 0.34 (95% CI 0–0.70) for AI/AN, and 1.31 (95% CI 1.00–1.53) for A/PI. PCNSL incidence for ages 20–49 years for Black patients was twice that for Whites. Incidence for ages over 49 years for Whites was twice that for Blacks. Survival at 12 months, 24 months, and 60 months was higher among Whites than Blacks. Research is needed to determine the origin of these differences.

Keywords: epidemiology, race

Received May 13, 2008; Accepted October 23, 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.